The role of human papillomavirus in oral carcinogenesis

Critical Reviews in Oral Biology and Medicine

Volumn 15, Issue 4, 2004, Pages 188-196

  Ha, Patrick K ^a   Califano, Joseph A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Head and neck cancer; Pre malignant

Indexed keywords

CARCINOGENESIS; GENOME; HUMAN; INFECTION RISK; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; GENETICS; ISOLATION AND PURIFICATION; MOUTH TUMOR; PAPILLOMA VIRUS; PATHOGENICITY; POLYMERASE CHAIN REACTION; PRECANCER; SQUAMOUS CELL CARCINOMA; VIROLOGY;

VIRUS DNA;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE;

EID: 4143132413     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130401500402     Document Type: Review

References (103)

1. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987). Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-971.
2. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, et al. (1995). Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 61:450-454.
3. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, et al. (2000). "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 13:644-653.
4. Boyer SN, Wazer DE, Band V (1996). E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620-4624.
5. Brandsma JL, Abramson AL (1989). Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115:621-625.
6. Brandsma J, Burk RD, Lancaster WD, Pfister H, Schiffman MH (1989). Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer 43:260-262.
7. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. (1996). Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488-2492.
8. Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, et al. (1996). The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174:927-936.
9. Combita AL, Bravo MM, Touze A, Orozco O, Coursaget P (2002). Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in Colombian women with invasive cervical cancer. Int J Cancer 97:796-803.
10. Cruz IB, Snijders PJ, Steenbergen RD, Meijer CJ, Snow GB, Walboomers JM, et al. (1996). Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 32B:55-62.
11. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR (1998). Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413-420.
12. de Villiers EM, Weidauer H, Otto H, zur Hausen H (1985). Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36:575-578.
13. Dyson N, Howley PM, Munger K, Harlow E (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
14. Eike A, Buchwald C, Rolighed J, Lindeberg H (1995). Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol 20:171-173.
15. Elamin F, Steingrimsdottir H, Wanakulasuriya S, Johnson N, Tavassoli M (1998). Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in UK subjects: a novel method of detection. Oral Oncol 34:191-197.
16. Evander M, Wadell G (1991). A general primer pair for amplification and detection of genital human papillomavirus types. J Virol Methods 31:239-250.
17. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 171:1026-1030.
18. Fouret P, Martin F, Flahault A, Saint-Guily JL (1995). Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 4:122-127.
19. Frazer IH, Leonard JH, Schonrock J, Wright RG, Kearsley JH (1993). HPV DNA in oropharyngeal squamous cell cancers: comparison of results from four DNA detection methods. Pathology 25:138-143.
20. Frisch M, Biggar RJ (1999). Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 354:1442-1443.
21. Gassenmaier A, Hornstein OP (1988). Presence of human papillomavirus DNA in benign and precancerous oral leukoplakias and squamous cell carcinomas. Dermatologica 176:224-233.
22. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720.
23. Greer RO, Eversole LR, Crosby LK (1990). Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies. J Oral Maxillofac Surg 48:1201-1205.
24. Gregoire L, Arella M, Campione-Piccardo J, Lancaster WD (1989). Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 27:2660-2665.
25. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, et al. (2002). Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8:1203-1209.
26. Hashida T, Yasumoto S (1991). Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J Gen Virol 72:1569-1577.
27. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM (1995). p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 55:4420-4424.
28. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240.
29. Holladay EB, Gerald WL (1993). Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol 100:36-40.
30. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991). p53 mutations in human cancers. Science 253:49-53.
31. Jalal H, Sanders CM, Prime SS, Scully C, Maitland NJ (1992). Detection of human papilloma virus type 16 DNA in oral squames from normal young adults. J Oral Pathol Med 21:465-470.
32. Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, et al. (1989). Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81:1698-1704.
33. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. (1996). Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 34:2095-2100.
34. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Munoz N, et al. (1993a). p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 143:1398-1405.
35. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, et al. (1993b). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992.
36. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT (1994). A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86:494-499.
37. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, et al. (2001). Prevalence distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92:2875-2884.
38. Lambropoulos AF, Dimitrakopoulos J, Frangoulides E, Katopodi R, Kotsis A, Karakasis D (1997). Incidence of human papillomavirus 6, 11, 16, 18 and 33 in normal oral mucosa of a Greek population. Eur J Oral Sci 105:294-297.
39. Lawton G, Thomas S, Schonrock J, Monsour F, Frazer I (1992). Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 21:265-269.
40. Lehn H, Krieg P, Sauer G (1985). Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc Natl Acad Sci USA 82:5540-5544.
41. Levine AJ (1990). The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177:419-426.
42. Liu X, Han S, Baluda MA, Park NH (1997). HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 14:2347-2353.
43. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H (1985). Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 84:417-420.
44. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, et al. (1992). Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 135:1093-1102.
45. Maitland NJ, Cox MF, Lynas C, Prime SS, Meanwell CA, Scully C (1987). Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 56:245-250.
46. Maitland NJ, Bromidge T, Cox MF, Crane IJ, Prime SS, Scully C (1989). Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction. Br J Cancer 59:698-703.
47. Mao EJ, Schwartz SM, Daling JR, Oda D, Tickman L, Beckmann AM (1996). Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 69:152-158.
48. Matzow T, Boysen M, Kalantari M, Johansson B, Hagmar B (1998). Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol 37:73-76.
49. McKaig RG, Baric RS, Olshan AF (1998). Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20:250-265.
50. Miguel RE, Villa LL, Cordeiro AC, Prado JC, Sobrinho JS, Kowalski LP (1998). Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg 176:428-429.
51. Miller CS, White DK (1996). Human papillomavirus expression in oral mucosa premalignant conditions and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:57-68.
52. Mineta H, Ogino T, Amano HM, Ohkawa Y, Araki K, Takebayashi S, et al. (1998). Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 18:4765-4768.
53. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. (2001). Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125-1131.
54. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421.
55. Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1-5.
56. Nagpal JK, Patnaik S, Das BR (2002). Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97:649-653.
57. Nielsen H, Norrild B, Vedtofte P, Praetorius F, Reibel J, Holmstrup P (1996). Human papillomavirus in oral premalignant lesions. Eur J Cancer B Oral Oncol 32(B):264-270.
58. Nishioka S, Fukushima K, Nishizaki K, Gunduz M, Tominaga S, Fukazawa M, et al. (1999). Human papillomavirus as a risk factor for head and neck cancers - a case-control study. Acta Otolaryngol Suppl 540:77-80.
59. Oda D, Bigler L, Lee P, Blanton R (1996). HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp Cell Res 226:164-169.
60. Ostwald C, Muller P, Barten M, Rutsatz K, Sonnenburg M, Milde-Langosch K, et al. (1994). Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 23:220-225.
61. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J (1991). Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12:1627-1631.
62. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP (1997). Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79:595-604.
63. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M (1999). Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 85:1903-1909.
64. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. (1990). Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82:1477-1484.
65. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT (2002). Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8:3187-3192.
66. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, et al. (2003). Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104:336-344.
67. Sand L, Jalouli J, Larsson PA, Hirsch JM (2000). Human papilloma viruses in oral lesions. Anticancer Res 20:1183-1188.
68. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
69. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
70. Schiffman MH (1992). Validation of hybridization assays: correlation of filter in situ dot blot and PCR with Southern blot. IARC Sci Publ 119:169-179.
71. Schneider-Gadicke A, Schwarz E (1986). Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 5:2285-2292.
72. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. (1998). Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90:1626-1636.
73. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
74. Shibata DK, Arnheim N, Martin WJ (1988). Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 167:225-230.
75. Shima K, Kobayashi I, Saito I, Kiyoshima T, Matsuo K, Ozeki S, et al. (2000). Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br J Oral Maxillofac Surg 38:445-450.
76. Shindoh M, Sawada Y, Kohgo T, Amemiya A, Fujinaga K (1992). Detection of human papillomavirus DNA sequences in tongue squamous-cell carcinoma utilizing the polymerase chain reaction method. Int J Cancer 50:167-171.
77. Shope R (1933). Infectious papillomatosis of rabbits. J Exp Med 58:607-624.
78. Shroyer KR, Greer RO (1991). Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol 71:708-713.
79. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH (1998). Human papillomavirus and risk of oral cancer. Laryngoscope 108:1098-1103.
80. Smith EM, Summersgill KF, Allen J, Hoffman HT, McCulloch T, Turek LP, et al. (2000). Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 109:1069-1076.
81. Snijders PJ, Meijer CJ, Walboomers JM (1991). Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection. J Gen Virol 72:2781-2786.
82. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT (1989). Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
83. Sugerman PB, Shillitoe EJ (1997). The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis 3:130-147.
84. Syrjanen SM (1990). Basic concepts and practical applications of recombinant DNA techniques in detection of human papillomavirus (HPV) infection (review article). APMIS 98:95-110.
85. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J (1983). Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12:418-424.
86. 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods 19:225-238.
87. Syrjanen SM, Syrjanen KJ, Happonen RP (1988b). Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization. J Oral Pathol 17:273-278.
88. Terai M, Hashimoto K, Yoda K, Sata T (1999). High prevalence of human papillomaviruses in the normal oral cavity of adults. Oral Microbiol Immunol 14:201-205.
89. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, et al. (1993). Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42:265-279.
90. Uobe K, Masuno K, Fang YR, Li LJ, Wen YM, Ueda Y, et al. (2001). Detection of HPV in Japanese and Chinese oral carcinomas by in situ PCR. Oral Oncol 37:146-152.
91. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, et al. (2001). Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93:232-235.
92. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L (1988). Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48:3780-3786.
93. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
94. Watts SL, Brewer EE, Fry TL (1991). Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 71:701-707.
95. Wen S, Tsuji T, Li X, Mizugaki Y, Hayatsu Y, Shinozaki F (1997). Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 17:307-311.
96. Werness BA, Levine AJ, Howley PM (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
97. White AE, Livanos EM, Tlsty TD (1994). Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666-677.
98. Wilczynski SP, Lin BT, Xie Y, Paz IB (1998). Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 152:145-156.
99. Yeudall WA, Campo MS (1991). Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 72:173-176.
100. Zeuss MS, Miller CS, White DK (1991). In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol 71:714-720.
101. Zumbach K, Hoffmann M, Kahn T, Bosch F, Gottschlich S, Gorogh T, et al. (2000). Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer 85:815-818.
102. zur Hausen H (1996). Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288:F55-F78.
103. zur Hausen H (2000). Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.